Hilary Butella
Behavioral Neurology & Neuropsychiatry · The Woodlands, TXNPI 1295221810
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 51.4% of the total. 2025 is the largest year on record at $25,448, more than ten times the $35 reported in 2020.
Across 704 payments — averaging $47.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$17K
- AbbVie$10K
- Otsuka America Pharmaceutical, Inc.$1K
- Lundbeck LLC$851
- Alkermes, Inc.$717
- Teva Pharmaceuticals USA, Inc.$592
- plus $3K from 19 others
What the payments were for
- Consulting fees$3,1889%
- Speaking & faculty fees$18,21054%
- Travel & lodging$8863%
- Food & beverage$11,29334%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 119 | $17,279 |
| AbbVie | 144 | $9,517 |
| Otsuka America Pharmaceutical, Inc. | 79 | $1,274 |
| Lundbeck LLC | 69 | $851 |
| Alkermes, Inc. | 49 | $717 |
| Teva Pharmaceuticals USA, Inc. | 29 | $592 |
| Neurocrine Biosciences, Inc. | 25 | $470 |
| Takeda Pharmaceuticals U.S.A., Inc. | 40 | $452 |
| Corium, LLC | 30 | $399 |
| Sunovion Pharmaceuticals Inc. | 16 | $344 |
| Bausch Health US, LLC | 24 | $325 |
| Tris Pharma Inc | 19 | $289 |
| Axsome Therapeutics, Inc. | 20 | $285 |
| Almatica Pharma LLC | 7 | $148 |
| Jazz Pharmaceuticals Inc. | 6 | $120 |
| Vanda Pharmaceuticals Inc. | 5 | $119 |
| Johnson & Johnson | 5 | $111 |
| Ironshore Pharmaceuticals Inc. | 4 | $81 |
| E.r. Squibb & Sons, L.L.C. | 3 | $77 |
| OWP Pharmaceuticals, Inc. | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Neos Therapeutics, LP | 2 | $28 |
| Noven Therapeutics, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few behavioral neurology & neuropsychiatry providers in Texasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 21 | $30,544 |
| VraylarCariprazine Hcl | 14 | $19,018 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,647 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 51 | $2,321 |
| Quetiapine Fumarate | 52 | $937 |
| Pregabalin | 22 | $510 |
| Bupropion XlBupropion Hcl | 31 | $464 |
| Olanzapine | 16 | $430 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $409 |
| Lamotrigine | 38 | $399 |
| Duloxetine Hcl | 17 | $333 |
| Ondansetron OdtOndansetron | 11 | $298 |
| Trazodone Hcl | 23 | $238 |
| Gabapentin | 21 | $190 |
| Doxepin Hcl | 14 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,274 | $30,54421 claims |
| AbbVieVraylar | $9,517 | $19,01814 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $452 | $5,64712 claims |
| Almatica Pharma LLCSertraline Hcl | $148 | $15322 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few behavioral neurology & neuropsychiatry providers in Texason file to place this against a meaningful peer group, so we don't.
Other behavioral neurology & neuropsychiatry in The Woodlands
- Paul SchulzHouston$854K
- John BertelsonAustin$313K
- Garima AroraSugar Land$5K
- Gabriel de ErausquinSan Antonio$3K
- David HunterHouston$1K
- Ricardo JorgeHouston$1K
- Melissa JonesHouston$885
- Tanveer KhanConroe$278
- Alicia ParkerSan Antonio$147
- Matthew AyersConroe$121
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.